FDA approves a 76-mm version of Abbott’s Esprit BTK resorbable scaffold system for patients with CLTI. The longer scaffold is intended to reduce the number of devices needed to treat long BTK lesions ...

Xeltis announced the official start of the European commercialization of aXess vascular access device for patients requiring hemod ...

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announ ...

Vesalio announced the appointment of Greg Cook as Chief Commercial Officer, responsible for leading the company’s commercial ...

The Society for Cardiovascular Angiography and Interventions (SCAI) announced that a multisociety expert consensus statement ...

Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.

HistoSonics announced that it has received approval in Europe for its Edison system, enabling the commercialization of the ...

Stereotaxis announced that it has completed its previously announced acquisition of Robocath, a Rouen, France-based developer ...

Glucagon‐like peptide‐1 receptor agonists (GLP-1 RAs) were shown to be associated with lower risks of death, hospitalization, ...

Endologix LLC announced 36-month results from the DETOUR2 clinical trial evaluating percutaneous transmural arterial bypass ...

Shape Memory Medical Inc., developer of a commercially available volume-expanding shape memory polymer for endovascular embolizatio ...

Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical ...